Vanguard Group Inc ownership in 1HM / Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation

DE ˙ MUN ˙ US00650F1093

13,58 € ↑0,76 (5,89%)

2026-06-04
AKTIENPREIS

Security	DE:1HM / Adaptive Biotechnologies Corporation
Institution	Vanguard Group Inc
Latest Disclosed Ownership	0 shares
Ownership	0.00%

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Adaptive Biotechnologies Corporation (DE:1HM). This represents 0.0 percent ownership of the company. In their previous filing dated 2024-11-12 , Vanguard Group Inc had reported owning 10,639,440 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File Date	Effective Date	Form	Prev Shares	Latest Shares	ΔShares (Percent)	Ownership (Percent)	ΔOwnership (Percent)
2026-03-26	2026-03-26	13G/A	10,639,440	0	-100.00	0.00	-100.00
2024-11-12	2024-11-12	13G/A	10,639,440	10,639,440	0.00	7.21	0.00
2024-11-04	2024-11-04	13G	12,767,684	10,639,440	-16.67	7.21	-18.25
2024-02-13	2024-02-13	13G/A	11,794,168	12,767,684	8.25	8.82	6.91
2023-02-09	2023-02-09	13G/A	11,031,288	11,794,168	6.92	8.25	5.50
2022-02-09	2022-02-09	13G/A	9,655,425	11,031,288	14.25	7.82	10.76
2021-02-10	2021-02-10	13G		9,655,425		7.06

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-01-29	2025-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,282,152	6,983	0.06	183,222	8.62	0.0027
2025-11-07	2025-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,275,169	-4,026	-0.04	168,677	28.37	0.0025
2025-08-11	2025-06-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,279,195	135,767	1.22	131,403	58.71	0.0021
2025-05-09	2025-03-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,143,428	428,540	4.00	82,796	28.89	0.0015
2025-02-11	2024-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	10,714,888	75,448	0.71	64,236	17.92	0.0011
2024-11-13	2024-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	10,639,440	412,529	4.03	54,474	47.14	0.0010
2024-08-13	2024-06-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	10,226,911	-2,642,907	-20.54	37,021	-10.39	0.0007
2024-05-10	2024-03-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	12,869,818	102,134	0.80	41,312	-33.97	0.0008
2024-03-11	2023-12-31	13F/A-1	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	12,767,684	518,642	4.23	62,562	-6.29	0.0014
2024-02-14	2023-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	12,767,684	518,642		62,562		0.0012
2023-12-18	2023-09-30	13F/A-1	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	12,249,042	196,555	1.63	66,757	-17.45	0.0016
2023-11-14	2023-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	12,249,042	196,555		66,757		0.0003
2023-08-14	2023-06-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	12,052,487	75,073	0.63	80,872	-23.53	0.0019
2023-07-14	2023-03-31	13F/A-1	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,977,414	183,246	1.55	105,761	17.37	0.0027
2023-05-15	2023-03-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,977,414	183,246		105,761		0.0027
2023-02-10	2022-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,794,168	122,385	1.05	90,107	8.43	0.0025
2022-11-14	2022-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,671,783	95,409	0.82	83,104	-11.26	0.0024
2022-08-12	2022-06-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,576,374	485,540	4.38	93,654	-39.16	0.0026
2022-05-13	2022-03-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,090,834	59,546	0.54	153,941	-50.27	0.0036
2022-02-14	2021-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	11,031,288	40,615	0.37	309,537	-17.14	0.0070
2021-11-12	2021-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	10,990,673	813,014	7.99	373,573	-10.17	0.0093
2021-08-13	2021-06-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	10,177,659	155,670	1.55	415,859	3.07	0.0103
2021-05-14	2021-03-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	10,021,989	366,564	3.80	403,485	-29.33	0.0109
2021-02-12	2020-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	9,655,425	2,589,318	36.64	570,925	66.15	0.0166
2020-11-16	2020-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	7,066,107	1,424,673	25.25	343,625	25.90	0.0114
2020-08-14	2020-06-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	5,641,434	1,169,653	26.16	272,933	119.71	0.0097
2020-05-15	2020-03-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	4,471,781	2,890,710	182.83	124,225	162.60	0.0053
2020-02-14	2019-12-31	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	1,581,071	84,685	5.66	47,305	2.31	0.0016
2019-11-14	2019-09-30	13F	ADAPTIVE BIOTECHNOLOGIES COR	COM	00650F109	1,496,386	1,296,386	648.19	46,238	378.65	0.0017
2019-08-14	2019-06-30	13F	ADAPTIVE BIOTECHNOLOGIES	COM	00650F109	200,000	200,000		9,660		0.0004

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.